Errors Coughed Up For Dextromethorphan, Guaifenesin In US FDA Electronic Registrations
Executive Summary
Three of seven businesses warned since February 2022 about noncompliance with FDA drug reporting requirements have been marketers of OTC cough/cold/congestion formulations made with dextromethorphan or guaifenesin.